Vext Science, Inc.
VEXTF
$0.18
$0.00-1.57%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.98% | 59.10% | 37.79% | 21.13% | 10.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.98% | 59.10% | 37.79% | 21.13% | 10.96% |
| Cost of Revenue | 73.36% | 24.18% | 31.55% | 23.02% | -5.20% |
| Gross Profit | 0.03% | 213.51% | 70.81% | 14.50% | 41.48% |
| SG&A Expenses | 1.03% | -4.15% | -12.22% | -62.14% | 11.64% |
| Depreciation & Amortization | 6.50% | 6.96% | 8.23% | 7.92% | 22.83% |
| Other Operating Expenses | -- | -- | -- | 37,500.00% | -- |
| Total Operating Expenses | 37.55% | 13.92% | 17.46% | -16.25% | 4.71% |
| Operating Income | -13.63% | 87.31% | 35.23% | 57.34% | 24.78% |
| Income Before Tax | -4.97% | 105.84% | 46.70% | -190.63% | 5.77% |
| Income Tax Expenses | -1.67% | 1,471.65% | 34.45% | -12.60% | 77.55% |
| Earnings from Continuing Operations | -5.29% | 66.33% | 47.36% | -263.73% | -35.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.29% | 66.33% | 47.36% | -263.73% | -35.79% |
| EBIT | -13.63% | 87.31% | 35.23% | 57.34% | 24.78% |
| EBITDA | -1.11% | 1,742.75% | 307.79% | 107.94% | 270.98% |
| EPS Basic | -3.92% | 66.48% | 51.96% | -238.29% | 17.07% |
| Normalized Basic EPS | 5.56% | 91.53% | 18.97% | 2.62% | 52.63% |
| EPS Diluted | -3.92% | 44.13% | 55.00% | -238.29% | 17.07% |
| Normalized Diluted EPS | 3.77% | 91.53% | 18.97% | 2.11% | 53.51% |
| Average Basic Shares Outstanding | 0.84% | 0.87% | 9.93% | 18.32% | 63.95% |
| Average Diluted Shares Outstanding | -0.42% | 0.87% | 9.82% | 17.75% | 66.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |